David Williams
Clinical trials sponsored by David Williams, explained in plain language.
-
Gene therapy offers hope for sickle cell patients by boosting healthy hemoglobin
Disease control TEMPORARILY_NOT_AVAILABLEThis study offers expanded access to a gene therapy for people with severe sickle cell disease. The treatment uses a modified virus to deliver genetic material that increases fetal hemoglobin, a healthy type that prevents sickling. Patients receive their own blood stem cells back…
Sponsor: David Williams • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Gene therapy could end pain crises for sickle cell patients
Disease control OngoingThis study tests a gene therapy that modifies a patient's own blood stem cells to produce more fetal hemoglobin, a healthy type that prevents sickling. The goal is to reduce or eliminate severe pain crises in people with sickle cell disease. The treatment involves chemotherapy to…
Phase: PHASE2 • Sponsor: David Williams • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Gene therapy aims to fix sickle cell disease from the inside
Disease control OngoingThis early-phase study tests a gene therapy approach for people with severe sickle cell disease. The treatment uses a modified virus to add a gene that boosts fetal hemoglobin, which can reduce sickling and symptoms. Ten participants will receive their own gene-corrected blood st…
Phase: PHASE1 • Sponsor: David Williams • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC